Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PHARMACEUTICAL COMPOSITION OF NEP INHIBITOR AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2016/086790
Kind Code:
A1
Abstract:
Disclosed are a pharmaceutical composition comprising a neutral endopeptidase (NEP) inhibitor and a use thereof in the preparation of a drug for treating and preventing diseases associated with NEP. The composition comprises: (i) (9R,11S)-11-([1,1'-biphenyl]-4-ylmethyl)-2,6,9-trimethyl-4,8,13-trioxo-3,5,7-trioxa-12-azahexadecane-16-acid (compound 1) or a pharmaceutical salt thereof, and/or (ii) an angiotensin II antagonist or a pharmaceutical salt thereof, and/or (iii) an angiotensin-converting enzyme inhibitor, and (iv) a pharmaceutically acceptable carrier.

Inventors:
WANG, Peiquan (Building 2, No.3728 Jinke Road Zhangjiang Hi-Tech Park, Shanghai 3, 201203, CN)
ZHANG, Lei (Building 2, No.3728 Jinke Road Zhangjiang Hi-Tech Park, Shanghai 3, 201203, CN)
LI, Chenghai (Building 2, No.3728 Jinke Road Zhangjiang Hi-Tech Park, Shanghai 3, 201203, CN)
BAO, Rudi (Building 2, No.3728 Jinke Road Zhangjiang Hi-Tech Park, Shanghai 3, 201203, CN)
XU, Yaochang (Building 2, No.3728 Jinke Road Zhangjiang Hi-Tech Park, Shanghai 3, 201203, CN)
Application Number:
CN2015/095626
Publication Date:
June 09, 2016
Filing Date:
November 26, 2015
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SHANGHAI HANSOH BIOMEDICAL CO., LTD (Building 2, No.3728 Jinke Road Zhangjiang Hi-Tech Park, Shanghai 3, 201203, CN)
JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD. (The 10th Industrial Sub-Zone of Development Zone, Lianyungang, Jiangsu 7, 222047, CN)
International Classes:
A61K31/216; A61K31/351; A61K31/40; A61K31/4015; A61K31/4178; A61K31/44; A61K31/54; A61P3/10; A61P9/04; A61P9/12; A61P13/12
Foreign References:
CN101119718A2008-02-06
Attorney, Agent or Firm:
GE CHENG & CO., LTD. (Level 19, Tower E3 The Towers, Oriental Plaza,No.1, East Chang An Avenue, Dongcheng District, Beijing 8, 100738, CN)
Download PDF: